Ilyang Pharmaceutical Co Ltd (007575) — Cash Flow Quality Index
Ilyang Pharmaceutical Co Ltd (007575) has a Cash Flow Quality Index of 3.92x as of June 2025. Operating cash flow of ₩2.26 Billion exceeds net income of ₩576.52 Million, indicating high earnings quality where cash backs reported profits. Explore cash flow to debt ratio of Ilyang Pharmaceutical Co Ltd to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Ilyang Pharmaceutical Co Ltd Cash Flow Quality Index (2015–2024)
Historical Cash Flow Quality Index for Ilyang Pharmaceutical Co Ltd across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Ilyang Pharmaceutical Co Ltd (007575) cash flow conversion.
Annual Cash Flow Quality Index for Ilyang Pharmaceutical Co Ltd (2015–2024)
Year-by-year earnings quality comparison for Ilyang Pharmaceutical Co Ltd.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.55x | ₩5.61 Billion | ₩10.26 Billion | ▼ -64.8% |
| 2022 | 1.56x | ₩29.94 Billion | ₩19.24 Billion | ▼ -66.6% |
| 2021 | 4.66x | ₩67.02 Billion | ₩14.38 Billion | ▼ -11.8% |
| 2020 | 5.28x | ₩57.48 Billion | ₩10.88 Billion | ▲ +45.8% |
| 2019 | 3.62x | ₩36.19 Billion | ₩9.98 Billion | ▼ -24.4% |
| 2017 | 4.79x | ₩30.03 Billion | ₩6.26 Billion | ▲ +4.9% |
| 2016 | 4.57x | ₩26.98 Billion | ₩5.91 Billion | ▼ -50.0% |
| 2015 | 9.13x | ₩40.27 Billion | ₩4.41 Billion | — |